Journal article icon

Journal article

Early HIV viral suppression associated with subsequent 12‐month treatment success among people living with HIV in South Africa

Abstract:
Background:
We analyzed the STREAM (Simplifying HIV TREAtment and Monitoring) study to determine risk factors associated with HIV viraemia and poor retention 18 months after initiation of antiretroviral therapy (ART).
Methods:
The STREAM study was an open-label randomized controlled trial in Durban, South Africa, that enrolled 390 people living with HIV presenting for their first HIV viral load measurement ~6 months after ART initiation. We used modified Poisson regression with robust standard errors to describe associations between baseline characteristics and three HIV outcomes 18 months after ART initiation: HIV viraemia (>50 copies/mL), poor retention in HIV care, and a composite outcome of poor retention in care and/or HIV viraemia.
Results:
Approximately 18 months after ART initiation, 45 (11.5%) participants were no longer retained in care and 43 (11.8%) had viraemia. People with CD4 counts <200 and those with viraemia 6 months after ART initiation were significantly more likely to have viraemia 18 months after ART initiation (adjusted relative risk [aRR] 4.0; 95% confidence interval [CI] 2.1-7.5 and aRR 5.5; 95% CI 3.3-9.0, respectively). People who did not disclose their HIV status and had viraemia after ART initiation were more likely to not be retained in care 12 months later (aRR 2.6; 95% CI 1.1-6.1 and aRR 2.2; 95% CI 1.0-4.8). People with a CD4 count <200 and those with viraemia were more likely to not achieve the composite outcome 18 months after ART initiation.
Conclusions:
Viraemia after ART initiation was the strongest predictor of subsequent viraemia and poor care retention. Understanding early indicators can help target our interventions to better engage people who may be more likely to experience persistent viraemia or disengage from HIV care.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1111/hiv.13633

Authors

More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Primary Care Health Sciences
Oxford college:
Green Templeton College
Role:
Author
ORCID:
0000-0001-6072-1430


More from this funder
Funder identifier:
https://ror.org/0187kwz08
Grant:
CL-2022-13-005
More from this funder
Funder identifier:
https://ror.org/00cvxb145


Publisher:
Wiley
Journal:
HIV Medicine More from this journal
Volume:
25
Issue:
6
Pages:
759-765
Place of publication:
England
Publication date:
2024-03-15
Acceptance date:
2024-03-02
DOI:
EISSN:
1468-1293
ISSN:
1464-2662
Pmid:
38488308


Language:
English
Keywords:
Pubs id:
1855362
Local pid:
pubs:1855362
Source identifiers:
W4392882929
Deposit date:
2026-05-29
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP